20 Dividend Stocks That Billionaires Are Piling On
Numerous billionaire money managers, including the likes of Warren Buffett and Ken Fisher, absolutely love dividend stocks (check out a list of Ken Fisher......(read more)
Posts Tagged ‘Gilead Sciences Inc (GILD)’
Billionaire Fund Managers Are Bullish On These Biotech Stocks
The biotech sector is well known for its M&A activity, but billionaire fund managers don’t seem to be attracted by the frenzy. They seem to prefer......(read more)
5 Best Quant Hedge Funds’ 5 Top Picks
Quantitative funds are gaining more ground among hedge funds in terms of trading volume and inflow of capital. According to The Wall Street Journal, this......(read more)
Cambrex Corporation (CBM): 33% Downside Risk According to Lakewood Capital Investor Letter
Analysts remain optimistic that Cambrex Corporation (NYSE:CBM) will enjoy revenue and earnings growth next year despite sales pressure on its leading......(read more)
15 Biggest Healthcare Companies in USA
If you’re seeking to invest in stocks with great long-term potential and are interested in adding some exposure to the healthcare sector, then the......(read more)
Should You Follow Hedge Funds Into These Healthcare Stocks?
Healthcare is a vast sector that nonetheless has huge growth prospects, with the U.S government and its citizens spending about $3 trillion annually......(read more)
11 Most Profitable Companies In The Fortune 500
What are the 11 Most Profitable Companies In The Fortune 500? Membership in the Fortune 500 is one of the most prestigious honors a company can have.......(read more)
11 Fastest Growing S&P 500 Companies in America
If, back in 2013, you invested in at least one of the 11 fastest growing S&P 500 companies in America, chances are that you are one happy (and possibly......(read more)
Dividend Stocks Hedge Funds Are Betting On
Dividends are an investor’s best friend. Not only does a solid sustained dividend illustrate dependability and competitiveness, but also the payout......(read more)
Is Gilead Sciences Worthy of Your Portfolio?
2016 was not a very good year for biotech stocks to say the least. The iShares NASDAQ Biotechnology Index (ETF) (NASDAQ:IBB) lost over 20%, as broader......(read more)
Are Hedge Funds Turning Bearish on Healthcare Stocks?
Healthcare stocks generally offer good dividend yields and a safe stream of cash flow given the recession-proof nature of the industry. However, hedge......(read more)
Gilead Sciences, Inc. (GILD) EPCLUSA Access To Be Provided In Ontario For Treatment Of Hepatitis C
Public access for Gilead Sciences, Inc. (NASDAQ:GILD) EPCLUSA will be provided in Ontario to adults who need the drug for the hepatitis C treatment. Besides......(read more)
10 Most Generous Companies In The US
The 10 most generous companies in the US are familiar and well-known names. Charity is good business for companies, especially in our modern times ......(read more)
Losses and Gains For Gilead Sciences, Inc. (GILD) Under President Trump Expected
There are almost too many speculations of changes to come in Washington, D.C. Small and big companies are all ears on the ground with expectations of......(read more)
Federal Judge Orders State Provide Mumia Abu-Jamal With HCV Treatment by Gilead Sciences, Inc. (GILD)
A federal judge in Pennsylvania has admonished the state for restricting inmates’ access to drugs and particularly those for hepatitis C. The antivirals......(read more)
Spring Bank Pharmaceuticals Inc (SBPH) An Ace Up Gilead Sciences, Inc. (GILD)’s Sleeve
While most westerners don’t have to worry about hepatitis B virus (HBV) due to currently available and effective vaccines, HBV is still an incurable......(read more)
Apple Inc, Gilead and Alphabet Inc: Can Analysts Predict Two Years Into The Future?
Apple Inc. shares currently trade at a trailing price earnings ratio of 14. Currently, analysts believe Apple will earn more than $10 per share next......(read more)
Gilead Sciences, Inc. (GILD) Is A Hail Mary: 3 Better Stocks To Consider
After a strong 2015, health care stocks are leading the way lower in 2016. And it’s been an even uglier year for biotechnology company Gilead Sciences......(read more)
GILD Stock: Can Gilead Sciences, Inc (GILD) Turn Around Its HCV Sales?
Are GILD Stock Investors Taking HCV Sales Concerns Too Seriously? Up to now, I have been very vocal with respect to my bullish opinion regarding Gilead......(read more)
GlaxoSmithKline PLC (ADR) (GSK) Phase 3 Trials Looks Positive: Will Gilead Sciences, Inc. (GILD) Endure?
Efforts by GlaxoSmithKline plc (ADR) (NYSE:GSK) in carrying out a large study on its new HIV drug are yielding positive results. The Phase III trial of......(read more)
AbbVie Inc (ABBV) Awaits NDA Approval For Hepatitis C Treatment
A New Drug Application (NDA) by AbbVie Inc (NYSE:ABBV) that will be used for the treatment of Hepatitis C is at the mercy the U.S. Food and Drug Administration......(read more)
Performance Of The Magic Formula Portfolio
Here’s a breakdown on how the Magic Formula Portfolio is performing. Since beginning this Shadow Stock Portfolio on June 1, 2016, it owns six stocks......(read more)
5 Healthcare Stocks Billionaires Love The Most
The election of Donald Trump has heralded an era of optimism in the healthcare industry, which has been one of the worst performing sectors over the......(read more)
Gilead Sciences, Inc. (GILD) Begins A Process That Could Alleviate Its Problems
Gilead Sciences, Inc. (NASDAQ:GILD) has switched course and has begun aggressive marketing of its HIV drug Truvada as a preventative medicine for HIV-......(read more)
Gilead Sciences, Inc. (GILD) Takes Lead Against AbbVie Inc (ABBV) On Crohn’s Disease Treatment
Gilead Sciences, Inc. (NASDAQ:GILD) might as well have quashed rumors making waves claiming it is planning to acquire Belgium-based Galapagos NV (ADR) (......(read more)
Matinas BioPharma Holdings Inc (MTNB) Can Take A $350M Antifungal Market From Gilead Sciences, Inc. (GILD)
In most cases a new method of drug delivery can occasionally alter markets a bit and cause some shifts. In rare cases though, it can fundamentally change......(read more)
What’s Next At GlobeImmune Inc (GBIM)?
GlobeImmune Inc (OTCMKTS:GBIM) shareholders did not have a good week last week. The company put out a press release outlining its latest developments,......(read more)
US Stock Charts And Ideas: Amazon (AMZN), Gilead (GILD), More
Today, I’m going to post some charts on a few trade setups that I’m focused on and which may provide a trade or two over the coming sessions. One......(read more)
ValueWorks’ Top Pick From Each of 5 Prominent Sectors: Gilead (GILD), Boeing (BA), More
ValueWorks LLC is a New York-based, value-focused long/short equity hedge fund founded in 2001 by Charles Lemonides, a CFA who previously served as the......(read more)
Julian Robertson Likes Biotech, Talks Up Microsoft (MSFT), Apple (AAPL) & Gilead (GILD)
Legendary investor Julian Robertson, founder of Tiger Management, sees tremendous upside in biotech stocks right now. The billionaire told CNBC in a......(read more)
Why Wells Fargo, Gilead, Newfield, Amgen, and Chesapeake Energy Are Trending
All three indexes are in the green today after U.S. consumer confidence jumped to its highest figure in nine years during September. According to the......(read more)
Why Traders Are Talking About Chevron, Adobe, Petrobras, and More
After being range-bound for the last few weeks, crude promises to be a little bit more volatile in the near-term following today’s release of......(read more)
Major Analyst Action Surrounding These Stocks Today
Equities have rebounded in trading today following the sell-off on Tuesday. Investors though remain anxious due to uncertainty over when the Federal Reserve......(read more)
Stock Market Highlights: 3D Printing Stocks, Analyst Upgrades & More
The US stock market is mixed on Tuesday amid news in the M&A space and Institute for Supply Management’s data that showed non-manufacturing......(read more)
VeriFone (PAY), Gilead (GILD) Among 5 Stocks That Hit 52-Week Lows Last Week
Although the S&P 500 and Dow Jones are near record highs, shares of five major companies crumbled to 52-week lows last week. In this article we’......(read more)
Five Healthcare Stocks Hedge Funds Like
Times are tough for healthcare stocks as investors keep a distance from the sector following drug-pricing control concerns and political clamor. However......(read more)
Earnings Reports Have Investors Abuzz About Gilead, Las Vegas Sands, 3 Other Stocks
Crude futures are again in the red as traders prepare for another API inventory release later today. We’re also in the heart of earnings season......(read more)
New York-Based Selz Capital’s Top Picks for Q3; High-Yielding Macquarie Infrastructure Corp (MIC) Retains Top Spot
The highly anticipated quarterly 13F filings for the second quarter of 2016 are slowing flowing in, enabling retail investors and analysts to examine......(read more)
Weekly Biotech Report Covering Gilead Sciences, Inc. (GILD) and Celyad SA (ADR) (CYAD)
For the section of our report detailing events in biotech this past couple of weeks, we’ve got two focus companies – one big, one small. They are......(read more)
How Did Hedge Funds’ Favourite Healthcare Stocks Perform during Q2?
Healthcare stocks, along with food and drink-related securities, are usually recommended as defensive holdings for recessions and bear markets, as individuals......(read more)
David Harding of Winton Capital Made Huge Gains on Brexit despite Backing the Remain Campaign
Although there was a ton of cash on the sidelines ahead the United Kingdom’s referendum on whether to leave the European Union or not, most hedge fund......(read more)
Here’s Why CVD Equipment, Micron and Three Other Stocks Are in Spotlight Today
Market sentiment is positive on Thursday after polls suggesting low chances of a Brexit. A decline in U.S. jobless claims last week to near a 43-year......(read more)
Mariner Investment’s Top Healthcare Picks
Among some 800 hedge funds we track at Insider Monkey, we seldom come across funds that specialize in investing in a particular sector or have a penchant......(read more)
Gabalex Capital Management’s Top Stock Picks for Q2
Nigel Greig and Kenneth Cowin’s Gabalex Capital recently submitted its 13F filing with the Securities and Exchange Commission for the reporting period......(read more)
Winton Capital Reduces Size of Several Top Holdings Entering Q2
Billionaire David Harding is a physicist by education, hence, it is no surprise that he trusts sophisticated computer models even when it comes to stock......(read more)
Amazon, LinkedIn, Gilead, & More: Here’s Why These Stocks Are Trending Today
At a time when crude futures have hit another monthly high and gold futures are strong, shares of Amazon.com, Inc. (NASDAQ:AMZN), LinkedIn Corp (NYSE......(read more)
How Hedge Funds’ Top Healthcare Bets Performed in Q1
Although the biotechnology sector was the most profitable sector in 2015, biotech stocks suffered the same fate as most others during the first quarter......(read more)
Five Healthcare Stocks Hedge Funds Are Bullish On
Since the beginning of 2016, the healthcare sector has been one of the worst performing and is down by almost 8.80% year-to-date, outperforming only the......(read more)
Healthinvest Partners’ Top Stock Picks For 2016
Sweden-based healthcare focused long/short equity hedge fund Healthinvest Partners AB was founded in 2006 by Anders Hallberg and Carl Bennet. The fund......(read more)
Highlights from Billionaire Jim Simons’ Renaissance Technologies’ 13F: Apple, Pfizer & More
Renaissance Technologies LLC (RenTech) is a New York-based hedge fund that Jim Simons founded in 1982. RenTech, and especially its Medallion Fund, has......(read more)
